Analysis of Geographic Areas
Edwards Lifesciences Corp. operates in 4 regions: United States; Europe; Japan; and Rest of World.
Area Asset Turnover
Edwards Lifesciences Corp., asset turnover by geographic area
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| United States | 2.48 | 2.32 | 2.98 | 3.20 | 3.13 |
| Europe | 6.01 | 5.05 | 9.27 | 24.18 | 29.26 |
| Japan | 26.85 | 22.55 | 20.49 | 59.22 | 46.09 |
| Rest of World | 1.64 | 1.40 | 1.59 | 1.80 | 2.48 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
| Europe | Europe area asset turnover ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. | |
| Japan | Japan area asset turnover ratio improved from 2019 to 2020 and from 2020 to 2021. | |
| Rest of World | Rest of World area asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |
Area Asset Turnover: United States
Edwards Lifesciences Corp.; United States; area asset turnover calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Net sales | 2,963,100) | 2,516,800) | 2,532,700) | 2,055,300) | 1,907,600) |
| Long-lived tangible assets | 1,195,800) | 1,084,300) | 849,100) | 642,100) | 608,700) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 2.48 | 2.32 | 2.98 | 3.20 | 3.13 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Area asset turnover = Net sales ÷ Long-lived tangible assets
= 2,963,100 ÷ 1,195,800 = 2.48
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Area Asset Turnover: Europe
Edwards Lifesciences Corp.; Europe; area asset turnover calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Net sales | 1,190,300) | 973,600) | 941,200) | 885,100) | 831,000) |
| Long-lived tangible assets | 197,900) | 192,700) | 101,500) | 36,600) | 28,400) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 6.01 | 5.05 | 9.27 | 24.18 | 29.26 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Area asset turnover = Net sales ÷ Long-lived tangible assets
= 1,190,300 ÷ 197,900 = 6.01
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Europe | Europe area asset turnover ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Area Asset Turnover: Japan
Edwards Lifesciences Corp.; Japan; area asset turnover calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Net sales | 528,900) | 460,100) | 444,700) | 396,800) | 350,300) |
| Long-lived tangible assets | 19,700) | 20,400) | 21,700) | 6,700) | 7,600) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 26.85 | 22.55 | 20.49 | 59.22 | 46.09 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Area asset turnover = Net sales ÷ Long-lived tangible assets
= 528,900 ÷ 19,700 = 26.85
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Japan | Japan area asset turnover ratio improved from 2019 to 2020 and from 2020 to 2021. |
Area Asset Turnover: Rest of World
Edwards Lifesciences Corp.; Rest of World; area asset turnover calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Net sales | 550,200) | 435,800) | 429,400) | 385,600) | 346,400) |
| Long-lived tangible assets | 335,500) | 311,000) | 269,400) | 214,400) | 139,700) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 1.64 | 1.40 | 1.59 | 1.80 | 2.48 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Area asset turnover = Net sales ÷ Long-lived tangible assets
= 550,200 ÷ 335,500 = 1.64
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Rest of World | Rest of World area asset turnover ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |
Net sales
Edwards Lifesciences Corp., net sales by geographic area
US$ in thousands
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| United States | 2,963,100) | 2,516,800) | 2,532,700) | 2,055,300) | 1,907,600) |
| Europe | 1,190,300) | 973,600) | 941,200) | 885,100) | 831,000) |
| Japan | 528,900) | 460,100) | 444,700) | 396,800) | 350,300) |
| Rest of World | 550,200) | 435,800) | 429,400) | 385,600) | 346,400) |
| Total | 5,232,500) | 4,386,300) | 4,348,000) | 3,722,800) | 3,435,300) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Long-lived tangible assets
Edwards Lifesciences Corp., long-lived tangible assets by geographic area
US$ in thousands
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| United States | 1,195,800) | 1,084,300) | 849,100) | 642,100) | 608,700) |
| Europe | 197,900) | 192,700) | 101,500) | 36,600) | 28,400) |
| Japan | 19,700) | 20,400) | 21,700) | 6,700) | 7,600) |
| Rest of World | 335,500) | 311,000) | 269,400) | 214,400) | 139,700) |
| Total | 1,748,900) | 1,608,400) | 1,241,700) | 899,800) | 784,400) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).